| Ytd | -81.17% | |
| 1y | -82.55% |
| Open | 5.45 | Prev Close | 5.84 | Low | 5.45 | High | 5.86 | Mkt Cap | 48.34M |
| Vol | 23.44K | Avg Vol | 134.20K | EPS | 0.24 | P/E | 23.42 | Forward P/E | N/A |
| Beta | 1.42 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-06 | 50-d Avg | 4.91 | 200-d Avg | 15.46 | 1yr Est | 0.00 |
SNWV News
SANUWAVE Health, Inc. (SNWV) Q2 2026 Earnings Call Transcript
Sanuwave Health NASDAQ: SNWV reported second-quarter 2026 revenue of $9.7 million, down 3% from $10.
Q2 2026 revenues were $9.7 million, down 3% from $10.1 million in Q2 2025. Q2 2026 gross margin was
SANUWAVE Health (NASDAQ:SNWV) reported quarterly losses of $(0.08) per share. This is a 100 percent
EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanu
Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday'
NASDAQ:SNWV shares are trading down 0.5% in premarket as SANUWAVE Health beats Q2 revenue expectatio
Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday
Gainers Exicure (NASDAQ:XCUR) stock rose 38.4% to $2.38 during Tuesday's after-market session.
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-
SANUWAVE Health (NASDAQ:SNWV) raises Q2 sales outlook from $8.500 million-$9.500 million to $9.600 m
EDEN PRAIRIE, Minn., July 13, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or “Sanu
Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m
Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provide
Sanuwave updates guidance for Q2 2026 to $8.5 - $9.5 million Company on pace for record unit sales o
Sanuwave Health NASDAQ: SNWV reported record first-quarter revenue and rising consumables utilizatio
SANUWAVE Health, Inc. (SNWV) Q1 2026 Earnings Call Transcript
Sanuwave Health Inc. (SNWV) came out with a quarterly loss of $0.17 per share versus the Zacks Conse
SANUWAVE Health (NASDAQ:SNWV) affirms FY2026 sales outlook from $51.000 million-$55.000 million to $
SANUWAVE Health (OTC:SNWV) reported quarterly losses of $(0.17) per share which missed the analyst c
Q1 2026 revenues were $9.6 million , up 3.1% from $9.3 million in Q1 2025. This represents the high
EDEN PRAIRIE, Minn. , May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanu
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely
Ayr Wellness (OTCMKTS:AYRWF - Get Free Report) and Sanuwave Health (NASDAQ: SNWV - Get Free Report)
Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provide
On April 10, 2026, SANUWAVE Health Inc (SNWV) shares fell 7.2% to a current price of $16.84. The sto
Sanuwave Health (NASDAQ: SNWV - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) are both
SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript
Q4 2025 revenues were $13.4 million , up 29.7% from Q4 2024. This was an all-time quarterly record
EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "San
Profitability This table compares Arch Therapeutics and SANUWAVE Health's net margins, return on equ
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Wednesday